News Focus
News Focus
icon url

hoffmann6383

10/17/22 11:58 PM

#522684 RE: HyGro #522683

yes, optune has difficulties getting approved in the UK as they fail the cost/benefit analysis but dcvax-l won't have the same problem
icon url

DocLee

10/18/22 11:46 AM

#522814 RE: HyGro #522683

UK is a minor market for pharmaceuticals.


On a point of information, is that in terms of total volume of pharmaceuticals prescribed annually or in total value (£ or $) of pharmaceuticals prescribed annually?